ROFLUMILAST
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
59651-275 -
Package NDC
59651-275-30 -
Package NDC
59651-275-90 -
Application number
ANDA213298 -
SPL ID
586e58c7-172f-4c3f-a91f-045ea4d089fc -
SPL set ID
7cb11d48-6bb9-437b-bc7f-382050a2d3e6 -
UNII
0P6C6ZOP5U -
RxCUI
1091839 -
RxCUI
2001319
What the source publishes
- Labeler
- Aurobindo Pharma Limited
- Active ingredients
- ROFLUMILAST
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "ROFLUMILAST",
"splId": "586e58c7-172f-4c3f-a91f-045ea4d089fc",
"labels": [
{
"setId": "7cb11d48-6bb9-437b-bc7f-382050a2d3e6",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7cb11d48-6bb9-437b-bc7f-382050a2d3e6",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7cb11d48-6bb9-437b-bc7f-382050a2d3e6"
}
],
"routes": [
"ORAL"
],
"labeler": "Aurobindo Pharma Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (59651-275-30)",
"package_ndc": "59651-275-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20230417"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (59651-275-90)",
"package_ndc": "59651-275-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20230417"
}
],
"productId": "59651-275_586e58c7-172f-4c3f-a91f-045ea4d089fc",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "59651-275",
"deaSchedule": null,
"genericName": "ROFLUMILAST",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ROFLUMILAST",
"strength": "500 ug/1"
}
],
"applicationNumber": "ANDA213298",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230417",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000182961",
"N0000182960"
],
"unii": [
"0P6C6ZOP5U"
],
"rxcui": [
"1091839",
"2001319"
],
"spl_set_id": [
"7cb11d48-6bb9-437b-bc7f-382050a2d3e6"
],
"pharm_class_epc": [
"Phosphodiesterase 4 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Phosphodiesterase 4 Inhibitors [MoA]"
],
"manufacturer_name": [
"Aurobindo Pharma Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:59651-275_586e58c7-172f-4c3f-a91f-045ea4d089fc"